Follow
Michelle Rudek
Michelle Rudek
Professor of Oncology and Medicine, Johns Hopkins University
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Combination epigenetic therapy has efficacy in patients with refractory advanced non–small cell lung cancer
RA Juergens, J Wrangle, FP Vendetti, SC Murphy, M Zhao, B Coleman, ...
Cancer discovery 1 (7), 598-607, 2011
7242011
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
SD Gore, S Baylin, E Sugar, H Carraway, CB Miller, M Carducci, M Grever, ...
Cancer research 66 (12), 6361-6369, 2006
5972006
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
F Ravandi, ML Alattar, MR Grunwald, MA Rudek, T Rajkhowa, MA Richie, ...
Blood, The Journal of the American Society of Hematology 121 (23), 4655-4662, 2013
4412013
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots, RR De Haas, H Dekker, ...
Clinical Cancer Research 17 (23), 7337-7346, 2011
3462011
A targeting modality for destruction of RNA polymerase I that possesses anticancer activity
K Peltonen, L Colis, H Liu, R Trivedi, MS Moubarek, HM Moore, B Bai, ...
Cancer cell 25 (1), 77-90, 2014
3082014
Modernizing clinical trial eligibility criteria: recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV working group
TS Uldrick, G Ison, MA Rudek, A Noy, K Schwartz, S Bruinooge, ...
Journal of clinical oncology: official journal of the American Society of …, 2017
3062017
The rising challenge of non–AIDS-defining cancers in HIV-infected patients
JF Deeken, A Tjen-A-Looi, MA Rudek, C Okuliar, M Young, RF Little, ...
Clinical infectious diseases 55 (9), 1228-1235, 2012
2792012
Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer
S Bisht, M Mizuma, G Feldmann, NA Ottenhof, SM Hong, D Pramanik, ...
Molecular cancer therapeutics 9 (8), 2255-2264, 2010
2632010
Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia
YB Chen, S Li, AA Lane, C Connolly, C Del Rio, B Valles, M Curtis, ...
Biology of Blood and Marrow Transplantation 20 (12), 2042-2048, 2014
2502014
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration‐resistant prostate cancer
ES Antonarakis, EI Heath, DC Smith, D Rathkopf, AL Blackford, DC Danila, ...
The oncologist 18 (2), 163-173, 2013
2042013
Targeting DDX 3 with a small molecule inhibitor for lung cancer therapy
GM Bol, F Vesuna, M Xie, J Zeng, K Aziz, N Gandhi, A Levine, A Irving, ...
EMBO molecular medicine 7 (5), 648-669, 2015
1972015
Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters
S Hu, Z Chen, R Franke, S Orwick, M Zhao, MA Rudek, A Sparreboom, ...
Clinical Cancer Research 15 (19), 6062-6069, 2009
1972009
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer
MA Rudek, WD Figg, V Dyer, W Dahut, ML Turner, SM Steinberg, ...
Journal of Clinical Oncology 19 (2), 584-592, 2001
1972001
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study
M Cianfrocca, TP Cooley, JY Lee, MA Rudek, DT Scadden, L Ratner, ...
Journal of clinical oncology 20 (1), 153-159, 2002
1962002
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
JH Kalin, M Wu, AV Gomez, Y Song, J Das, D Hayward, N Adejola, M Wu, ...
Nature communications 9 (1), 53, 2018
1932018
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study
HJ Hammers, HM Verheul, B Salumbides, R Sharma, M Rudek, J Jaspers, ...
Molecular cancer therapeutics 9 (6), 1525-1535, 2010
1892010
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
R Pili, B Salumbides, M Zhao, S Altiok, D Qian, J Zwiebel, MA Carducci, ...
British journal of cancer 106 (1), 77-84, 2012
1752012
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan
NPH Van Erp, SD Baker, M Zhao, MA Rudek, HJ Guchelaar, JWR Nortier, ...
Clinical cancer research 11 (21), 7800-7806, 2005
1712005
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer
RK Anchoori, B Karanam, S Peng, JW Wang, R Jiang, T Tanno, ...
Cancer cell 24 (6), 791-805, 2013
1662013
Use of antineoplastic agents in patients with cancer who have HIV/AIDS
MA Rudek, C Flexner, RF Ambinder
The lancet oncology 12 (9), 905-912, 2011
1452011
The system can't perform the operation now. Try again later.
Articles 1–20